Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
Impact of Goal-directed Hemodynamic Management on Occurrence of Acute and Persistent Kidney Injury After Radical Nephrectomy or Nephroureterectomy: A Randomized Controlled Trial
Sponsor: Peking University First Hospital
Listed as NCT05149196, this NA trial focuses on Acute Kidney Injury and Chronic Kidney Diseases and remains actively recruiting participants. Sponsored by Peking University First Hospital, it has been updated 7 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2024 — Jun 2025 [monthly]
Not Yet Recruiting NA
-
Oct 2024 — Nov 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
▶ Show 2 earlier versions
-
May 2022 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Jan 2022 — May 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University First Hospital
For direct contact, visit the study record on ClinicalTrials.gov .